Phase 2 Readout
BIVI: Phase 2 Readout: bezisterim
June 30, 2026 · bezisterim. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 30, 2026
- Company
- BIOVIE INC. (BIVI)
- Drug
- bezisterim
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: bezisterim
- Company
- BIOVIE INC. (BIVI)
- Drug
- bezisterim
- Indication
- Parkinson's Disease